Last update 01 Nov 2024
ADU-1604
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism CTLA4 inhibitors(Cytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with ADU-1604A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ADU-1604, an Anti-CTLA-4 Antibody, in Adults With Metastatic Melanoma
- SRP-21C101
100 Clinical Results associated with ADU-1604
Login to view more data
100 Translational Medicine associated with ADU-1604
Login to view more data
100 Patents (Medical) associated with ADU-1604
Login to view more data
100 Deals associated with ADU-1604
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Melanoma | Phase 1 | FR | 08 Nov 2018 | |
| Melanoma | Phase 1 | ES | 08 Nov 2018 | |
| Metastatic melanoma | Phase 1 | FR | 08 Nov 2018 | |
| Metastatic melanoma | Phase 1 | ES | 08 Nov 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | Refractory Melanoma ICOS | Ki-67 | ALC | - | ADU-1604 25 mg | yijuuhmiow(xcfchqmica) = dose-dependent increase of ALC and CD4+ and CD8+ T cells dziysxrlhn (lvrapamazo ) View more | - | 02 Nov 2023 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free